IL-18 could have a pro-tumoral activity in certain types of cancers, such as in pancreatic cancer and multiple myeloma, as discussed in this review, and the source and frequency of IL-18 release may contribute to its effect. The gene discussed is IL18; the disease is familial pancreatic carcinoma.